May 28, 4:44 PM EDT
Media & Culture
Osteoporosis Drugs Require Better Labeling, FDA Recommends
on 09/10/11 AT 7:06 AM
Warner Chilcott Plc (WCRX), Roche Holding AG (ROG), Merck & Co. and Novartis AG (NOVN) need to change the labeling of Bisphosphonates, a medicine taken by patients to prevent and cure osteoporosis, the FDA said.